Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Global Analytical Instrument and Lab Product Industry: Annual Growth and Vendor Share Estimates for 10 Markets
09:18am, Friday, 24'th Apr 2020
Dublin, April 24, 2020 -- The "2020 Annual Review and Industry Forecast Issue" report has been added to ResearchAndMarkets.com's offering. The annual.
Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
12:00am, Friday, 24'th Apr 2020The basis of glyphosate resistance in amaranth
05:06pm, Thursday, 23'rd Apr 2020
William T. Molin (U.S. Department of Agriculture-Agricultural Research Service, Stoneville, MS) teamed up with Allison Yaguchi, Mark Blenner, and Christopher A. Saski (Clemson University, SC) to seque
Analytical Instrument and Lab Product Industry Forecast and Annual Review 2020 - ResearchAndMarkets.com
10:39am, Wednesday, 22'nd Apr 2020
The "2020 Annual Review and Industry Forecast Issue" report has been added to ResearchAndMarkets.com's offering.
Pacific Biosciences of California (NASDAQ:PACB) Upgraded to "Sell" by BidaskClub
07:38am, Wednesday, 22'nd Apr 2020
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday, BidAskClu
Pacific Biosciences of California (NASDAQ:PACB) Short Interest Update
06:04am, Wednesday, 22'nd Apr 2020
Pacific Biosciences of California (NASDAQ:PACB) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 18,350,000 shares, a
Pacific Biosciences' Sequel II Gets Acquired by inqaba biotec
11:22am, Tuesday, 21'st Apr 2020
Pacific Biosciences' (PACB) new development is likely to boost the company's flagship platform, the Sequel system.
Pacific Biosciences' Sequel II Gets Acquired by inqaba biotec
11:22am, Tuesday, 21'st Apr 2020
Pacific Biosciences' (PACB) new development is likely to boost the company's flagship platform, the Sequel system.
Geode Capital Management LLC Boosts Stake in Pacific Biosciences of California (NASDAQ:PACB)
10:02am, Tuesday, 21'st Apr 2020
Geode Capital Management LLC grew its position in shares of Pacific Biosciences of California (NASDAQ:PACB) by 6.2% during the fourth quarter, Holdings Channel reports. The fund owned 2,024,408 shares
Havens Advisors Llc Buys Legg Mason Inc, Forty Seven Inc, The Stars Group Inc, Sells WellCare ...
12:00am, Tuesday, 21'st Apr 2020BRIEF-Inqaba Biotec Acquires The First Pacbio Sequel II System In Africa
11:39am, Monday, 20'th Apr 2020
Pacific Biosciences of California Inc :
inqaba biotec acquires the first PacBio Sequel II System in Africa
11:00am, Monday, 20'th Apr 2020
Pacific Biosciences of California, Inc. (PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, and inqaba biotec, the leading commercial DNA sequencing servi
Assenagon Asset Management S.A. Purchases Shares of 1,531,350 Pacific Biosciences of California (NASDAQ:PACB)
08:48am, Monday, 20'th Apr 2020
Assenagon Asset Management S.A. purchased a new stake in Pacific Biosciences of California (NASDAQ:PACB) during the 1st quarter, according to the company in its most recent Form 13F filing with the Se
